20 of the UK’s top innovative healthcare technology companies to visit Silicon Valley

20 of the UK’s top innovative healthcare technology companies to visit Silicon Valley

07 Dec 2010

A select group of the UK’s most successful and promising healthcare technology businesses have been awarded the opportunity to take part in a mission to Silicon Valley. For one week they will showcase their unique technologies and work towards opening up their businesses to an international market.

The Future Health Mission 2011 will give the entrepreneurs behind these growing healthcare technology companies the opportunity to engage with key people from the US’s top technology businesses. With current health requirements stimulating the need for business innovation, the UK companies will see just how US businesses are addressing emerging market opportunities. The mission, which takes place 8-14 January 2011, is designed to ensure that the 20 businesses taking part benefit from the collective impact of a well-run trade mission.

The companies, already highly successful in the UK, will meet the media as well as peers from around the world, investors and potential partners. They will also engage with experts on the financial and public policy agendas relevant to healthcare technology businesses operating in the US.

The mission is delivered and supported by the Technology Strategy Board, UK Trade and Investment, Polecat, Silicon Valley Bank and McKinsey with other sponsors expected to announce their support soon. The goal of the mission is to help entrepreneurs in the UK’s healthcare technology sector to take their businesses into the global marketplace. 

Iain Gray, Chief Executive of the Technology Strategy Board, commented:

“Each of the successful 20 companies is a pioneer and we are working with them because we want to see these businesses find their place in what looks set to become a fast growing international market. We are pleased to be working alongside UKTI and other partners to support these growing businesses.”

Matthew Durdy, CEO of Aqix Ltd whose company has developed a unique synthetic human interstitial fluid, commented:

“The Future Health Mission is a fantastic opportunity for Aqix to showcase our pioneering health technology in the US as well as exchange knowledge, expertise and contacts with our American counterparts. Over the past five years Aqix has grown into a thriving UK business and we’re now looking forward to demonstrating our potential for commercial success on a global scale.”

For full press release including notes to editors please follow this link

Media contact:

For further information and media support in the run up to, or during the mission (including opportunities to interview individual businesses and representatives from all of the organisations involved) please contact:

Claire Cunningham
Media Relations Manager
Technology Strategy Board
Tel: 01793 442901
Mob: 07554 115745
Email: claire.cunningham@tsb.gov.uk

Tim Cockroft
Reynolds MacKenzie
Tel: 0207 812 7123
Mob: 07957 325 583
Email: timothy@reynoldsmackenzie.com



Last updated on Tuesday 07 December 2010 at 11:03

More like this

Copyright © 2013